A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Clinical trial NCT01868061 · COMPLETED
Trial details
- NCT number
- NCT01868061
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-31
- Primary completion
- 2017-01-02
- Enrollment
- 1068
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.